AzTrials
AzTrials

OsteoporosisTINEPCAWONCT06969313

Telemedicine Intention, Need, Expectations, and Perceived Challenges Among Women With Osteoporosis

An observational study of Osteoporosis and Telemedicine, run by Antalya Training and Research Hospital at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to explore the needs and expectations of women with postmenopausal osteoporosis regarding telemedicine services. Osteoporosis is a common condition among postmenopausal women that increases the risk of fractures and significantly affects quality of life. Read more about this study

Who is it for?
Ages 50 to 85 years, women onlyHealthy volunteers can take part
Conditions the study is for
Osteoporosis, Telemedicine
What is being tested?
Structured Questionnaire on Telemedicine Needs
How many people
197 participants
Where
2 sitesTurkey (Türkiye)
Study dates
1 Feb 2025to 9 May 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 85 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population will include postmenopausal women aged 50 to 85 years with a confirmed diagnosis of osteoporosis. Participants will be recruited from patients attending the Physical Medicine and Rehabilitation Department of Antalya City Hospital and the Gynecology Department of Antalya Anadolu Hospital. To reduce selection bias, a systematic sampling method was employed, whereby every third consecutive woman with osteoporosis who presented to the outpatient clinics during the data collection period was invited to participate in the study.

Who may be able to join

  • Female patients aged 50 to 85 years. Diagnosed with osteoporosis (based on clinical evaluation and prior diagnosis). Able to understand and complete the study questionnaire (adequate cognitive function).
  • Willing and able to provide informed consent and voluntarily participate in the study.

Who cannot join

  • Presence of severe medical conditions that may interfere with participation, including:
  • Severe cardiac diseases (e.g., advanced heart failure). Severe pulmonary diseases (e.g., advanced chronic obstructive pulmonary disease).
  • Advanced-stage cancer or other life-limiting illnesses. Cognitive impairment preventing understanding or completion of the questionnaire.
  • Participation in another clinical or interventional study at the same time. Recent significant trauma (physical or psychological) that may interfere with study participation.
  • Individuals who cannot understand the study goals and risks, or who refuse informed consent.

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Antalya City Hospital

    Antalya, 07080

  • Antalya Anatolia Hospital

    Antalya

Other trials in Turkey (Türkiye)

About this study

This study aims to explore the needs and expectations of women with postmenopausal osteoporosis regarding telemedicine services. Osteoporosis is a common condition among postmenopausal women that increases the risk of fractures and significantly affects quality of life. Many patients do not receive enough information about their disease and treatments during routine clinic visits, which may affect their ability to manage osteoporosis effectively. Participants will be divided into two age groups: those younger than 65 and those aged 65 or older. These subgroups will be compared in terms of their willingness to use telemedicine, their perceived need for such services, their expectations, preferred service topics, and anticipated barriers.

Telemedicine-including video consultations, remote monitoring, and online health education-can offer support to patients, especially for those facing difficulties in accessing healthcare, such as elderly individuals, those living in rural areas, or people with mobility issues.

Read more

In this research, women aged 50 to 85 who have been diagnosed with postmenopausal osteoporosis will be asked to complete a survey. The survey includes questions about their needs for telemedicine services, including which types of services (such as medication counseling, exercise programs, dietary advice, psychological support) would be most helpful for them.

The study will also examine if age, education level, past fractures, or family history of osteoporosis influence patients' preferences for telemedicine. By identifying these needs, this research aims to improve access to healthcare and develop personalized telemedicine services for women with osteoporosis in Turkey.

This is a non-interventional, observational, and anonymous survey-based study that will take approximately 10-15 minutes to complete. No medications, treatments, or physical tests will be applied.

Read the detailed description

This observational, cross-sectional study investigates the actual needs, preferences, and expectations of postmenopausal women with osteoporosis regarding the use of telemedicine services. Osteoporosis is a chronic, progressive condition characterized by decreased bone density and increased fracture risk, which can significantly impair mobility, and overall quality of life. Access to ongoing medical support is crucial for these patients, yet many-particularly older individuals-encounter substantial barriers such as physical limitations, transportation difficulties, limited caregiver availability, or lack of local specialist services.

Telemedicine has gained prominence as a solution to these challenges, offering remote access to healthcare services through technologies like video consultations, telephone check-ins, and online education tools. While telemedicine has been widely implemented during the COVID-19 pandemic, there remains a lack of data on how women with postmenopausal osteoporosis view these services, what features they find most useful, and what obstacles they anticipate.

The primary objective of this study is to evaluate which types of telemedicine services are most needed and preferred by this patient population-for example, support related to medication use, exercise programs, and dietary advice. The study also aims to determine whether specific sociodemographic and clinical variables-such as age, education level, marital status-are associated with participants' willingness to use telemedicine and their actual need for it.

To examine age-related differences, participants will be divided into two subgroups: those under 65 years of age and those aged 65 or older. These subgroups will be compared across multiple domains, including their interest in using telemedicine, actual necessity for such services (calculated according to parameters living alone, not driving/owning a car, having a chronic disease other than osteoporosis), expectations for care delivery, preferred content areas, and potential barriers (such as lack of internet access or digital literacy).

Data will be collected using a structured, self-administered questionnaire developed through expert consultation and adapted from validated tools in previous telehealth research. The questionnaire includes closed-ended questions and will be distributed during routine outpatient visits at two regional hospitals. Participants will be informed about the purpose of the study and assured of full anonymity and confidentiality. Completing the questionnaire is voluntary and is estimated to take approximately 10-15 minutes.

By identifying telemedicine-related needs specific to postmenopausal women with osteoporosis, this study seeks to support the creation of age-appropriate, patient-centered telehealth models. These findings may also inform healthcare providers and policymakers on how to design and implement accessible, effective, and equitable digital healthcare interventions to improve long-term disease management and patient outcomes in this growing patient population.

Being tested
Structured Questionnaire on Telemedicine Needs
Keywords
telemedicine, telehealth, patient needs, osteoporosis
Medical subject headings
Osteoporosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Structured Questionnaire on Telemedicine NeedsOther

    Also called There is no other intervention.

    Participants will complete a structured questionnaire designed to assess their telemedicine needs, expectations, and current knowledge. The questionnaire includes items on demographics, osteoporosis management, and telemedicine service expectations. No clinical or pharmacological intervention will be applied.

Study groups in NCT06969313
Study groupRoleWhat they receive
Younger age groupParticipants will be divided into two age groups. The younger age group will include participants below 65.
Receives: Other: Structured Questionnaire on Telemedicine Needs
Older age groupParticipants will be divided into two age groups. The older age group will include participants equal to or above 65.
Receives: Other: Structured Questionnaire on Telemedicine Needs

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intention to Use Telemedicine Services

    Participants were directly asked in the questionnaire about their willingness to use telemedicine services. Response options included "Yes," "Not sure," and "No."

    Measured: Day 1

  2. Telemedicine Needs Index

    The Telemedicine Need Index was calculated based on three demographic factors: living alone (scored 1), not driving or owning a car (scored 1), and having a chronic disease other than osteoporosis (scored 1). These scores were summed, yielding a total score ranging from 0 to 3. A score of 2 or higher indicated a high need for telemedicine services. Higher scores reflected a greater need for telemedicine.

    Measured: Day 1

  3. Differences of telemedicine willingness and need between age groups

    Intention to use telemedicine services (answers as yes, not and not sure) and the need for telemedicine (Telemedicine Need Index (scored 0 to 3)) were compared between younger (below 65) older (equal to or above 65) participant.

    Measured: Day 1

Secondary outcomes (3)
  1. Patient-reported barriers to telemedicine use

    Identification of barriers via questionnaire (technological, privacy, etc.).

    Measured: Day 1

  2. Preferred topics for telemedicine services

    Patient preferences for telemedicine content (e.g., medication, diet).

    Measured: Day 1

  3. Perceived impact of telemedicine on Quality of Life

    Likert-scale rating of expected impact of telemedicine on quality of life. Participants rated the perceived impact of telemedicine on their quality of life using a 5-point Likert scale: 1 = Not effective at all, 2 = Slightly effective, 3 = Moderately effective, 4 = Very effective, 5 = Extremely effective. Higher scores indicate a stronger belief that telemedicine services will improve quality of life.

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2025
  2. Study start1 Feb 2025
  3. Primary completion1 May 2025
  4. Study completion9 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
197 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06969313
Sponsor's protocol ID
Antalya City Hospital
Acronym
TINEPCAWO
Status last verified
May 2025
First submitted
28 Apr 2025
Last updated
25 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: IPD related to demographics (such as age and education level, marital status), and responses to the telemedicine needs questionnaire will be available upon reasonable request from the corresponding author. No personally identifiable information will be shared.

Publications

  • Sasaki R, Yunoki T, Nakano Y, Fukui Y, Takemoto M, Morihara R, Abe K, Yamashita T. Actual Telemedicine Needs of Japanese Patients with Neurological Disorders in the COVID-19 Pandemic. Intern Med. 2023 Feb 1;62(3):365-371. doi: 10.2169/internalmedicine.9702-22. Epub 2022 Nov 23.

    PubMed 36418105
  • Palacios S, Neyro JL, Fernandez de Cabo S, Chaves J, Rejas J. Impact of osteoporosis and bone fracture on health-related quality of life in postmenopausal women. Climacteric. 2014 Feb;17(1):60-70. doi: 10.3109/13697137.2013.808182. Epub 2013 Jul 30.

    PubMed 23710562
  • Sood S, Mbarika V, Jugoo S, Dookhy R, Doarn CR, Prakash N, Merrell RC. What is telemedicine? A collection of 104 peer-reviewed perspectives and theoretical underpinnings. Telemed J E Health. 2007 Oct;13(5):573-90. doi: 10.1089/tmj.2006.0073.

    PubMed 17999619

Questions about this trial

What is this clinical trial studying?

An observational study of Osteoporosis and Telemedicine, run by Antalya Training and Research Hospital at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intention to Use Telemedicine Services (time frame: Day 1). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06969313, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in